REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmoris Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Other Basic Inorganic Chemical Manufacturing | Other Basic Organic Chemical Manufacturing | Pharmaceutical Preparation Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Pharmoris Sp. z o.o. Profile Updated: April 29, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Pharmoris Sp. z o.o. is an enterprise located in Poland, with the main office in Rumia. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on April 20, 2012. It currently has a total number of 2 (2014) employees. The company’s latest financial report indicates a net sales revenue increase of 38178.94% in 2023. Over the same period, its total assets grew by 37.57%.

Headquarters
Ul. Oliwska 47/1
Rumia; Pomorskie; Postal Code: 84-230

Contact Details: Purchase the Pharmoris Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmoris Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Pharmoris Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Pharmoris Sp. z o.o. report to view the information.
Incorporation Date:
April 20, 2012
Key Executives
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
91.03%
Company Performance
Financial values in the chart are available after Pharmoris Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
38178.94%
Total operating revenue
35701.61%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
37.57%
Total equity
5.63%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?